# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Stephens & Co. analyst Andrew Terrell maintains Glacier Bancorp (NYSE:GBCI) with a Equal-Weight and lowers the price tar...
DA Davidson analyst Jeff Rulis maintains Glacier Bancorp (NYSE:GBCI) with a Buy and lowers the price target from $48 to $45.
Truist Securities analyst Brandon King maintains Glacier Bancorp (NYSE:GBCI) with a Hold and lowers the price target from $4...
Stephens & Co. analyst Andrew Terrell reiterates Glacier Bancorp (NYSE:GBCI) with a Equal-Weight and maintains $44 price...
Glacier Bancorp (NYSE:GBCI) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.33...
Glacier Bancorp, Inc. (NYSE:GBCI) today announced that its banking subsidiary, Glacier Bank, has received all regulatory approv...
Companies Reporting Before The Bell • Addex Therapeutics (NASDAQ:ADXN) is estimated to report earnings for its fourth quarter.
Truist Securities analyst Brandon King maintains Glacier Bancorp (NYSE:GBCI) with a Hold and lowers the price target from $4...